SB 184 requires certain health coverage arrangements in Indiana to pay for “clean dietary supplements” when they are prescribed by a health care provider. The bill applies to three categories of coverage: state employee health plans, individual and group accident and sickness insurance policies, and health maintenance organization contracts. It would take effect for plans and contracts established, issued, delivered, amended, or renewed after June 30, 2025.
The bill defines “clean dietary supplement” narrowly to include collagen protein, 5-hydroxytryptophan (5-HTP), pan 10x, iodine, vitamin D, and magnesium. In each covered setting, the supplement must be prescribed to the covered person or enrollee by a physician-services provider as defined in existing law. The bill adds new sections to the Indiana Code in the state employee health plan chapter, the accident and sickness insurance chapter, and the HMO chapter.
Impact
SB 184 would expand mandated health insurance benefits in Indiana by requiring coverage for specified dietary supplements across state employee plans, private accident and sickness policies, and HMO contracts. It would amend Title 5 and Title 27 of the Indiana Code by creating new coverage provisions and definitions, thereby affecting insurers, HMOs, state plan administrators, employers offering covered plans, and covered individuals who receive prescriptions for the listed supplements.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of support or opposition from legislative discussion. Based on the bill text alone, the measure appears consumer- and coverage-expanding in nature, which may appeal to advocates for broader access to prescribed supplements. At the same time, because it creates a new mandated benefit, it could draw concern from insurers and plan sponsors about added costs and the precedent of covering supplements rather than traditional prescription drugs.
Contention
The main likely point of contention is whether the listed supplements should be treated as medically necessary covered benefits under insurance law, especially given that the bill mandates coverage for a small, specific set of products. Insurers and employers may object to premium or plan-cost impacts and to the administrative burden of adding a new mandated benefit. Supporters would likely emphasize access for patients whose providers prescribe these supplements and the bill’s limited scope to only certain named items.